Literature DB >> 28593655

Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa.

Alessandro Giollo1, Luca Idolazzi1, Cristian Caimmi1, Angelo Fassio1, Francesco Bertoldo2, Riccardo Dalle Grave3, Marwan El Ghoch3, Simona Calugi3, Paola Vittoria Bazzani4, Ombretta Viapiana1, Maurizio Rossini1, Davide Gatti1.   

Abstract

OBJECTIVE: The aim of the study was to investigate a potential role for vitamin D status on bone mineral density (BMD) during weight gain in patients with anorexia nervosa (AN).
METHOD: Spine and hip BMD assessed by dual-energy X-ray absorptiometry (DXA), serum vitamin D (25-OH-D), N-propeptide of type I collagen (P1NP), C-terminal telopeptide of type I collagen (CTX), and intact parathyroid hormone (PTH) were measured before and after a 20-week intensive weight-restoration program in ninety-one female patients with AN and secondary amenorrhoea.
RESULTS: Ninety-one consecutive female patients (age 13-45 years; weight 39.4 ± 5.6 kg, body mass index [BMI] 15.1 ± 1.6 kg m-2 ) were included in the study. Although weight and BMI significantly increased in all patients during treatment, mean BMD only significantly increased at the spine (1.0% ± 3.6%, p = .009). The increase in spine BMD was significantly higher only above post-treatment 25-OH-D levels of 30 ng mL-1 (2.5% vs. 0.5%, respectively, for 25-OH-D ≥ and < 30 ng mL-1 , p = .026). There was a significant decrease in bone resorption (CTX; p = .043) and increased bone formation (P1NP; p < .001) after weight restoration. Nevertheless, a significant increase in PTH was also found, which was inversely correlated with decreased post-treatment 25-OH-D levels (R2  = .153, p < .001). DISCUSSION: Hypovitaminosis D may counteract the efficacy of refeeding in AN through increased bone resorption mediated by secondary hyperparathyroidism, which strongly supports the use of vitamin D supplements for bone health in AN.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28593655     DOI: 10.1002/eat.22731

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  6 in total

1.  Anorexia Nervosa and Bone.

Authors:  Melanie Schorr; Anne Klibanski
Journal:  Curr Opin Endocr Metab Res       Date:  2018-01-31

2.  Bone mass and biomarkers in young women with anorexia nervosa: a prospective 3-year follow-up study.

Authors:  Anna Svedlund; Cecilia Pettersson; Bojan Tubic; Lars Ellegård; Anders Elfvin; Per Magnusson; Diana Swolin-Eide
Journal:  J Bone Miner Metab       Date:  2022-08-12       Impact factor: 2.976

Review 3.  Anorexia nervosa: COVID-19 pandemic period (Review).

Authors:  Mihai Cristian Dumitrașcu; Florica Șandru; Mara Carsote; Razvan Cosmin Petca; Ancuta Augustina Gheorghisan-Galateanu; Aida Petca; Ana Valea
Journal:  Exp Ther Med       Date:  2021-05-26       Impact factor: 2.447

Review 4.  Genetic contributions to the etiology of anorexia nervosa: New perspectives in molecular diagnosis and treatment.

Authors:  Stefano Paolacci; Aysha Karim Kiani; Elena Manara; Tommaso Beccari; Maria Rachele Ceccarini; Liborio Stuppia; Pietro Chiurazzi; Laura Dalla Ragione; Matteo Bertelli
Journal:  Mol Genet Genomic Med       Date:  2020-05-05       Impact factor: 2.183

Review 5.  Psychiatric and medical comorbidities of eating disorders: findings from a rapid review of the literature.

Authors:  Ashlea Hambleton; Genevieve Pepin; Anvi Le; Danielle Maloney; Stephen Touyz; Sarah Maguire
Journal:  J Eat Disord       Date:  2022-09-05

6.  Absence of relationships between depression and anxiety and bone mineral density in patients hospitalized for severe anorexia nervosa.

Authors:  J Herrou; N Godart; A Etcheto; S Kolta; N Barthe; A Y Maugars; T Thomas; C Roux; K Briot
Journal:  Eat Weight Disord       Date:  2020-10-21       Impact factor: 4.652

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.